contraindications for glp 1 agonists include switching GLP-1 Medications: Everything You Need

Since the cost of these drugs can be prohibitive, these findings could have a major real-world impact, says Mitch Biermann, MD, PhD, an author of the study and an obesity medicine and internal medicine doctor at Scripps Clinic Carmel Valley in California

[DOI] [PubMed] 45.Gornik HL, Aronow HD, Goodney PP, et al

To date, the trial has enrolled 94 participants, with 54 in the T2DM group and 40 in the obesity group

They discovered that the people who had obesity-related cancer in these four categories (lung, breast, colon, liver) and were also taking GLP-1s to manage diabetes, had a 38% to 50% lower risk of their cancer advancing to stage 4

Wegovy comes in five dose strengths : 0.25 mg, 1 mg, 1.7 mg, or 2.4 mg

10.1210/en.2009-1272 15 BloughB.MorelandA.MoraA